Reset filter
Mots-clés
Médecine vasculaire ×
Afficher plus Mots-clés
Table des matières
  1. 1. Essai clinique
  2. 2. Routinedokumentation
  3. 3. Études de registres/cohortes
  4. 4. Assurance qualité
  5. 5. Standard de données
  6. 6. Questionnaire pour les patients
  7. 7. Spécialité médicale
    1. 7.1. Anesthésie
    1. 7.2. Dermatologie
    1. 7.3. HNO
    1. 7.4. Gériatrie
    1. 7.5. Gynécologie/obstétrique
    1. 7.6. Médecine interne
      1. Hématologie
      1. Infectiologie
      1. Cardiologie/angiologie
      1. Pneumologie
      1. Gastroentérologie
      1. Néphrologie
      1. Endocrinologie/métabolisme
      1. Rhumatologie
    1. 7.7. Neurologie
    1. 7.8. Ophtalmologie
    1. 7.9. Médecine palliative
    1. 7.10. Pathologie/médécine légale
    1. 7.11. Pédiatrie
    1. 7.12. Psychiatrie/psychosomatique
    1. 7.13. Radiologie
    1. 7.14. Chirurgie
      1. Chirurgie générale/viscérale
      1. Neurochirurgie
      1. Chirurgie plastique
      1. Chirurgie cardiaque/thoracique
      1. Chirurgie traumatologique/orthopédie
      1. Chirurgie vasculaire
    1. 7.15. Urologie
    1. 7.16. Médecine dentaire/MKG
Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

87 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

ATRIA Stroke Risk Score

- 25/01/2018 - 1 Formulaire, 1 Groupe Item, 9 Eléments de données, 1 Langue
Groupe Item: ATRIA Stroke Risk Score
The ATRIA stroke risk score can be used to optimize optimize anticoagulation decision making in patients with atrial fibrillation (AF) by predicting severe events. Reference: Singer, D. E., Chang, Y., Borowsky, L. H., Fang, M. C., Pomernacki, N. K., Udaltsova, N., ... & Go, A. S. (2013). A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. Journal of the American Heart Association, 2(3), e000250. Publication granted by Daniel E. Singer.

CEC - Stroke/TIA study Chronic Coronary Heart Disease NCT00799903 - CEC - Stroke/TIA GSK study Chronic Coronary Heart Disease NCT00799903

- 11/01/2018 - 1 Formulaire, 3 Groupes Item, 26 Eléments de données, 1 Langue
Groupes Item: CEC - MI, Stroke - CEC Section, CEC STATUS
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: CEC - Stroke/TIA Repeating form (Scheduled visits)

Endpoint Stroke/TIA GSK study Chronic Coronary Heart Disease NCT00799903

- 04/01/2018 - 1 Formulaire, 3 Groupes Item, 55 Eléments de données, 1 Langue
Groupes Item: Investigator Section, CEC Section, CEC STATUS
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Endpoint Stroke/TIA - Repeating form (Scheduled visits)

Fondaparinux sodium (Arixtra) versus unfractionated heparin with patients undergoing PCI; Clinical Study ID: AR1104574 - Stroke Report

- 13/08/2018 - 1 Formulaire, 2 Groupes Item, 14 Eléments de données, 1 Langue
Groupes Item: Administrative Data, Cerebrovascular event
Study ID: 104574 Clinical Study ID: AR1104574 Study Title: A randomized blinded pilot trial of fondaparinux sodium (Arixtra®) versus unfractionated heparin in addition to standard therapy in a broad range of patients undergoing percutaneous coronary intervention (ASPIRE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thromboembolism

DZHK Data Catalogue - MRI

- 16/10/2019 - 1 Formulaire, 5 Groupes Item, 29 Eléments de données, 2 Langues
Groupes Item: MRI details, Cine 4-chamber view, Cine 2-chamber view, Short-axis cine stack, Late Gadolinium Enhancement (LGE) details
With permission from the DZHK administrative office. http://dzhk.de The DZHK (Deutsches Zentrum für Herz-Kreislauf-Forschung e.V.; German Center for Cardiovascular Research) is a joint cooperation of twenty-eight institutions in seven locations throughout Germany to develop a common research strategy. They developed a data catalogue with metadata and data as well as information about available biological materials from all their studies. For more information on the data catalogue and access to actual data and biosamples please visit https://dzhk.de/en/resources/data-manual/ . This version contains the metadata part only. The form MRI is used to document analyzing parameters of cardiac magnetic resonance imaging examinations. The documentation is to be performed according to the DZHK's SOPs, which can be accessed at https://dzhk.de/en/resources/sops/ (or https://dzhk.de/ressourcen/sops/ for the German language versions). The SOPs for this form are "Cardiac magnetic resonance imaging" (version 1.0, effective as of 01/09/2014), and "Kardiale Magnetresonanztomographie" (version 1.0, effective as of 01/09/2014), for the English and German versions, respectively. The SOP is ased on the guidelines of the Society for Cardiovascular Magnetic Resonance (Kramer CM et al. Journal of Cardiovascular Magnetic Resonance 2008, 10:35 and Journal of Cardiovascular Magnetic Resonance 2013, 15:91). Contraindications to MRI are: - Pacemakers, defibrillators - Neurostimulators - Metal vascular clips - Cochlear implants - Ferromagnetic intravascular filters and shunts that were implanted less than 1 month ago - Starr-Edwards prosthetic heart valves (old type of heart valve made of metal, implanted prior to 1970) - Recently implanted ferromagnetic vascular clips - Implanted permanent magnets (magnetic dentures) - Implanted insulin or pain pumps - Recently implanted joint replacement, magnetic resonance imaging is safe with titanium prostheses or joint replacements that were implanted a while ago - Shrapnel

CHA2DS2-VASc score

- 27/09/2021 - 1 Formulaire, 1 Groupe Item, 8 Eléments de données, 1 Langue
Groupe Item: CHADS2
The CHA2DS2-VASc is a simple stroke risk stratification schema for patients with atrial fibrillation which is based on a risk factor approach and provides some improvement in predictive value for TE over the CHADS 2 schema. Reference: Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest Journal, 137(2), 263-272.

CHADS2 score

- 25/01/2018 - 1 Formulaire, 1 Groupe Item, 6 Eléments de données, 1 Langue
Groupe Item: CHADS2
The CHADS2 can quantify risk of stroke for patients who have atrial fibrillation (AF) and may aid in selection of antithrombotic therapy. Reference: Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001). Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. Jama, 285(22), 2864-2870.

EHR Medical History Cardiac Patients - Anamnese Kardiologische Patienten

- 27/09/2021 - 1 Formulaire, 2 Groupes Item, 68 Eléments de données, 2 Langues
Groupes Item: Medical History, Indication and clinical question
EHR Medical History Cardiac Patients. From the University Hospital of Münster, Germany, Department of Nuclear Medicine. AN MS MSZ Studie NUK

Eligibility Heart Failure NCT01589601

- 12/01/2020 - 1 Formulaire, 2 Groupes Item, 17 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Palliative Care in Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT01589601

NINDS CDE Cardiac End Points Friedreich´s Ataxia - Cardiac End Points

- 04/05/2016 - 1 Formulaire, 1 Groupe Item, 8 Eléments de données, 1 Langue
Groupe Item: Cardiac End Points
NINDS Common Data Elements (Cardiac End Points; Friedreich´s Ataxia) Used from the National Institute of Neurological Disorders and Stroke Common Data Elements (https://www.commondataelements.ninds.nih.gov/) References: Grinnon ST, Miller K, Marler JR, Lu Y, Stout A, Odenkirchen J, Kunitz S. National Institute of Neurological Disorders and Stroke Common Data Element Project - approach and methods. Clin Trials. 2012;9(3):322-9.

Eligibility Atrial Fibrillation NCT01150214

- 30/07/2019 - 1 Formulaire, 2 Groupes Item, 11 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
DECAAF: Delayed-Enhancement MRI (DE-MRI) Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation; ODM derived from: https://clinicaltrials.gov/show/NCT01150214

Eligibility Syncope NCT01965899

- 28/09/2021 - 1 Formulaire, 2 Groupes Item, 15 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor System; ODM derived from: https://clinicaltrials.gov/show/NCT01965899

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial